Invention Grant
US09326973B2 Hepatitis C virus inhibitors 有权
丙型肝炎病毒抑制剂

Hepatitis C virus inhibitors
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
Public/Granted literature
Information query
Patent Agency Ranking
0/0